Funding cuts and regulatory changes could radically reduce Medicaid, the largest program providing medical and health-related ...
The directive for the Department of Health and Human Services to develop and test new models aimed at lowering drug costs ...
Trump’s executive order halts an effort to cap the copayment for generic medications at $2 for Medicare beneficiaries.
The Trump administration came into office earlier this week with a promise of cutting down on government spending and driving ...
The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare ...
The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...
CMS issued the industry-wide ratings the next month. Among large insurers, UnitedHealthcare experienced one of the most dramatic drops in scores. In its lawsuit, the UnitedHealth Group subsidiary ...
The U.S. health agency, the Centers for Medicare & Medicaid Services (CMS), announced Tuesday that it will appeal a November 2024 ruling to the Fifth Circuit Court of Appeals. What Happened: In ...
In November, a federal judge ordered CMS to recalculate UnitedHealthcare's Medicare Advantage Star Ratings for the 2025 plan ...
Medicare and Medicaid are major sources of government spending, yet Democrats and Republicans alike support funding the ...
Soon, the Centers for Medicare and Medicaid Services will begin the price negotiation process on a new set of 15 drugs. The new Trump administration should seize the opportunity to change the ...